Member Article

IDS acquires Italian company

Boldon-based drug testing company, Immunodiagnostic Systems Holdings PLC, has announced its acquisition of Italian company Diametra.

Diametra, based in Spello, Umbria, employs 25 staff and generated revenues of £2.65 million for the year ending 31 December 2013.

IDS has reportedly made the acquisition as part of a strategy to build its presence as a solution provider for speciality testing.

Prior to the acquisition, IDS and DIametra had been collaborating for 9 months.

The acquisition will now provide IDS with further development and manufacturing capabilities.

CEO of IDS, Patrik Dahlen, said: “ We are delighted to have secured the acquisition of Diametra, which will assist in the acceleration of our strategic plan outlined earlier this year.

“In particular, Diametra will provide immediate access to endocrinology manual assays in the area of steroid hormones that can be converted to automated assays for our iSYS instrument.

“We continue to pursue complementary acquisitions that will help us grow our specialist endocrinology menu and build operational excellence.”